Allan Geliebter, PhD

Loading Events

← Back to Events

Allan Geliebter, PhD

May 2024

GLP-1 Agonists: A New Frontier In The Treatment of Obesity

May 30
Faculty House, 64 Morningside Drive
New York,

There is considerable excitement about a new generation of anti-obesity medications (AOMs). These medications supply the body with analogues of hormones that are naturally produced in the gut, including glucagon-like-peptide-1 (GLP-1), which signal the termination of eating and suppress hunger. Recent clinical trials demonstrate marked efficacy of GLP-1-based AOMs in promoting weight loss with some evidence that their primary mechanism of action is to limit food intake. Although work is needed to precisely characterize effects on eating behaviors, initial data…

Find out more »
+ Export Events